ClinicalTrials.Veeva

Menu

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation (ERADICATE)

AdventHealth logo

AdventHealth

Status

Enrolling

Conditions

Adenoma Colon Polyp

Study type

Observational

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT06476145
1880214

Details and patient eligibility

About

Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)

Enrollment

342 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 years or older
  2. Ability to provide informed consent
  3. Patient scheduled to undergo colonoscopy for the evaluation and removal of colon polyps
  4. Non-pedunculated polyps ≥ 20 mm size

Exclusion criteria

  1. Pedunculated polyps
  2. Inflammatory bowel disease
  3. Inability to provide informed consent
  4. Lesions < 20 mm in size (largest dimension)
  5. Lesion involves the lips of the ileocecal valve, is located at the appendiceal orifice and/or is fully circumferential.
  6. Any standard contraindication, including pregnancy, to anesthesia and/or colonoscopy

Trial design

342 participants in 2 patient groups

EMR-MM
Description:
Mucosal markings are placed clearly outside the visible margin of the lesion (polyp) by placing superficial cautery marks with the tip of the endoscopic snare approximately 3 mm away from the polyp margin. Successful marking with diathermy is established by visual identification of white circular "dots" around the entire outer border of the lesion. EMR is then performed as per standard technique as described above.
EMR-STSC
Description:
Endoscopic mucosal resection with thermal margin ablation (STSC) will be performed of the entire margin of the mucosal defect, by using a light touch with 1 to 2 mm of the exposed snare tip aiming to create a 2 to 3 mm rim of completely ablated tissue around the entire circumference of the resection defect. Successful STSC is confirmed by the presence of a rim of whitening mucosa around the defect

Trial contacts and locations

1

Loading...

Central trial contact

Diana Paredes, RN; Petronio Martins, MHA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems